Back

Device-detected subclinical atrial fibrillation should be treated like clinical atrial fibrillation – the final word.

27 August 2022 (09:00 - 09:15)
Organised by:
Congress Presentation Part of: Great Debate: device-detected subclinical AF should be treated like clinical AF. All patients with HF and AF should undergo AF ablation Stroke Treatment ESC Professional Premium Access ESC Congress 2022

5 More presentations in this session

Presentation thumbnail
Device-detected subclinical atrial fibrillation should be treated like clinical atrial fibrillation: pro.
Professor G. Boriani (Modena, IT)
Slides Video
Presentation thumbnail
Device-detected subclinical atrial fibrillation should be treated like clinical atrial fibrillation: con.
Professor I. Van Gelder (Groningen, NL)
Slides Video
Presentation thumbnail
All patients with heart failure and atrial fibrillation should undergo atrial fibrillation ablation: pro.
Professor L. Di Biase (The Bronx, US)
Slides Video
Presentation thumbnail
All patients with heart failure and atrial fibrillation should undergo atrial fibrillation ablation: con.
Doctor A. Verma (Montreal, CA)
Slides Video
Presentation thumbnail
All patients with heart failure and atrial fibrillation should undergo atrial fibrillation ablation – the final word.
Video

Access the full session

Session thumbnail
Great Debate: device-detected subclinical AF should be treated like clinical AF. All patients with HF and AF should undergo AF ablation
Video

The Event

Event poster

ESC Congress 2022

27 August 2022 09:00 CET
You may be interested in
thumbnail
Congress Session
EHRA Myths - Device-detected atrial fibrillation
thumbnail
Congress Session
Stroke prevention in clinical and subclinical atrial fibrillation
thumbnail
Congress Session
Oral anticoagulation in subclinical atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources